Literature DB >> 10357030

The prevalence of depression in Alzheimer's disease and vascular dementia in a population sample.

S C Newman1.   

Abstract

BACKGROUND: Previous studies have shown that depression is more prevalent in vascular dementia than Alzheimer's disease (AD). Subjects for these studies were either psychiatry or neurology patients, raising the issue of whether factors leading to treatment might have introduced sampling bias.
METHODS: Data for the present study came from the Canadian Study of Health and Aging (CSHA, 1994), a population-based prevalence study of dementia. AD was diagnosed using NINCDS-ADRDA criteria (McKhann et al., 1984), vascular dementia was diagnosed using draft ICD-10 criteria (World Health Organization, 1987) and the Ischemic Scale (Hachinski et al., 1975), major depression was diagnosed using an algorithm based on DSM-III-R criteria (American Psychiatric Association, 1987). The sample for the present study consisted of 481 subjects with AD and 140 with vascular dementia.
RESULTS: The weighted prevalence rate of major depression was 3.2% for AD and 21.2% for vascular dementia, giving a crude odds ratio of 8.2 (95% Confidence Interval: 1.7-40.2). This finding was confirmed by a logistic regression analysis which adjusted for age, sex, place of residence (community, institution), self-reported health, severity of cognitive impairment, and antidepressant or beta-blocker use. LIMITATIONS: Data on depressive symptoms were more often missing in subjects with dementia resulting in differential loss of potential study subjects. Data on depressive symptoms were not sufficiently detailed to permit DSM-III-R criteria to be implemented rigorously. The method of diagnosing vascular dementia was subject to misclassification.
CONCLUSIONS: This study confirms in a population sample that depression is more prevalent in vascular dementia compared to AD.

Entities:  

Mesh:

Year:  1999        PMID: 10357030     DOI: 10.1016/s0165-0327(98)00070-6

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  18 in total

1.  Gene-environment interplay in affect and dementia: emotional modulation of cognitive expression in personal outcomes.

Authors:  T Palomo; R J Beninger; R M Kostrzewa; T Archer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

2.  Prevalence of Depression, Anxiety and PTSD in People with Dementia: a Systematic Review and Meta-Analysis.

Authors:  J K Kuring; J L Mathias; L Ward
Journal:  Neuropsychol Rev       Date:  2018-12-07       Impact factor: 7.444

Review 3.  Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug TV3326 [(N-propargyl-(3R)aminoindan-5-YL)-ethyl methyl carbamate].

Authors:  M B Youdim; M Weinstock
Journal:  Cell Mol Neurobiol       Date:  2001-12       Impact factor: 5.046

4.  Clinical and radiological characteristics of early versus late mild cognitive impairment in patients with comorbid depressive disorder.

Authors:  Jeffrey N Motter; Gregory H Pelton; Kristina D'Antonio; Sara N Rushia; Monique A Pimontel; Jeffrey R Petrella; Ernst Garcon; Michaela W Ciovacco; Joel R Sneed; P Murali Doraiswamy; Davangere P Devanand
Journal:  Int J Geriatr Psychiatry       Date:  2018-07-23       Impact factor: 3.485

Review 5.  Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimer's disease.

Authors:  Orly Weinreb; Tamar Amit; Orit Bar-Am; Moussa B H Youdim
Journal:  Br J Pharmacol       Date:  2015-12-01       Impact factor: 8.739

Review 6.  Depressive symptoms in neurodegenerative diseases.

Authors:  Miquel Baquero; Nuria Martín
Journal:  World J Clin Cases       Date:  2015-08-16       Impact factor: 1.337

Review 7.  Multifunctional neuroprotective derivatives of rasagiline as anti-Alzheimer's disease drugs.

Authors:  Orly Weinreb; Silvia Mandel; Orit Bar-Am; Merav Yogev-Falach; Yael Avramovich-Tirosh; Tamar Amit; Moussa B H Youdim
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

8.  Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia.

Authors:  Deborah E Barnes; Kristine Yaffe; Amy L Byers; Mark McCormick; Catherine Schaefer; Rachel A Whitmer
Journal:  Arch Gen Psychiatry       Date:  2012-05

Review 9.  Depression in nursing homes: ensuring adequate treatment.

Authors:  Robert H Llewellyn-Jones; John Snowdon
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 10.  What are the causes of late-life depression?

Authors:  Rehan Aziz; David C Steffens
Journal:  Psychiatr Clin North Am       Date:  2013-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.